Вопросы теоретической экономики

Литература

1. Карательная психиатрия в России (2004). [Punitive psychiatry in Russia (2004) / L.A. Bashinova (ed.) et al.] Л.А. Башинова (ред.) и др. М.: МХГ. URL: https://protivpytok.org/wp-content/uploads/2012/01/ps.pdf. (дата обращения: 10.07.2023).
2. Чирикова А. Е., Шишкин С. В. (2019). Эффективный контракт и мотивация: способны ли реформы улучшить работу российских врачей? [Chirikova A., Shishkin S. (2019). Efective contract and motivation: could the reform to improve Russian physicians’ work quality?] // Социологические исследования. № 5. С. 36-44. DOI: 10.31857/S013216250004952-0 (дата обращения: 10.07.2023).
3. Хайнцен Дж. (2021). Искусство взятки. Коррупция при Сталине 1943-1953[Heinzen J. (2021). The Art of the Bribe. Corruption Under Stalin, 1943–1953]. — М.: РОССПЭН.
4. Шишкин С.В. (2000). Реформа финансирования российского здравоохранения [Shishkin S. (2000). The Reform of Russian Healthcare funding]. — М.: ИЭПП «Научные труды» № 25-р. URL: https://www.iep.ru/files/text/working_papers/25.pdf (дата обращения: 16.07.2023).
5. Шишкин С.В., Бесстремянная Г.Е., Красильникова М.Д., Овчарова Л.Н., Чернец В.А., Чирикова А.Е., Шилова Л.С.. (2004). Российское здравоохранение: оплата за наличный расчет [Shishkin S., Besstremyannaya G., Krasilnikova M., Ovcharova L., Chernetz V., Chirikova A., Shilova L. (2004). Russian Healthcare: cash payments]. — М.: Независимый институт социальной политики. URL: https://publications.hse.ru/books/54925986 (дата обращения: 11.07.2023).
6. Шишкин С., Потапчик Е., Селезнева Е. (2013). Частный сектор здравоохранения в России: состояние и перспективы развития [Shishkin S., Potapchik E., Selezneva E. (2013). Private sector in Russian Healthcare: current State and Prospects of Development] // Вопросы экономики. № 4 C. 94-112. DOI: 10.32609/0042-8736-2013-4-94-112
7. Яновский К. (2022). Пандемия COVID-19: Как правительства старых демократий принимали решения [Yanovskiy K. (2022). How old Democracies’ Governments’ Decision making has worked in case of COVID-19 Responses’ Choice] // Вопросы теоретической экономики. №1 С. 58-73. URL: http://questionset.ru/files/arch/2022/2022-N1/Yanovsky_VTE_2022_1.pdf (дата обращения: 11.07.2023). DOI: 10.52342/2587-7666VTE_2022_1_58_73.
8. Яновский К. (2019). Дополнительные материалы по истории благотворительности в США и обзор некоторых мотивов пожертвований к главе 7 книги «Стратегия долгосрочного процветания: в поисках растаявшего ориентира» (М.: Дело, 2018). [Yanovskiy K. (2019). Supplementals on the History of Charity in the US to the book ‘The Strategy of Lasting Prosperity: In Search for the lost Constellation’]. DOI: 10.2139/ssrn.3461196 (дата обращения: 11.07.2023).
9. Яновский К., Э. Жаворонков С.В. (2019). Всемогущее правительство, поддержанное «научным консенсусом» [Yanovskiy K., Zhavoronkov S. (2019). Unlimited Government Endorsed by “Scientific Consensus”] // Общественные науки и современность. №6. С. 91-103. DOI: 10.31857/S086904990007570-9
10. Яновский К., Жаворонков С., Черный Д. (2017). Дополнительные материалы по истории государственного здравоохранения к книге «Стратегия долгосрочного процветания: в поисках растаявшего ориентира» [Yanovskiy K., Zhavoronkov S., Cherny D. (2017). Supplementals on the History of Government run Healthcare to the book «The Strategy of Lasting Prosperity: In Search for the lost Constellation»]. DOI: 10.13140/RG.2.2.33099.08482. (дата обращения: 11.07.2023).
11. Яновский К., Жаворонков С., Черный Д, Затковецкий И. (2018). Стратегия долгосрочного процветания: в поисках растаявшего ориентира [Yanovskiy K., Zhavoronkov S., Cherny D. Zatcovetsky I. (2018). The Strategy of Lasting Prosperity: In Search for the Lost Constellation]. — М.: Дело.
12. Acemoglu D., Johnson S., Robinson J. (2003). Disease and Development in Historical Perspective // Journal of the European Economic Association, MIT Press. Vol. 1. No 2-3. Pp. 397-405. URL: https://www.jstor.org/stable/40005189 (access date: 23.07.2023).
13. Ameriks J., Caplin A., Laufer S., Vannieuwerburgh S., (2011). The Joy of Giving or Assisted Living? Using Strategic Surveys to Separate Public Care Aversion from Bequest Motives // The Journal of Finance. Vol. 66. No. 2. Pp. 519-561. DOI: 10.1111/j.1540-6261.2010.01641.x
14. Annas G., Grodin M. (2018). Reflections on the 70th Anniversary of the Nuremberg Doctors' Trial // American Journal of Public Health. Vol. 108 No 1. Pp. 10-12. DOI: 10.2105%2FAJPH.2017.304203
15. Armentano D.T. (1986). Antitrust Policy: The Case for Repeal. — Washington, DC: Cato Institute.
16. Benkler Y. (2019). Don’t let industry write the rules for AI // Nature. Vol. 569 No& 7755. Pp. 161. DOI: 10.1038/d41586-019-01413-1
17. Bodde D. (1963). Basic Concepts of Chinese Law: The Genesis and Evolution of Legal Thought in Traditional China // Proceedings of the American Philosophical Society. Vol. 107. No. 5 Pp. 375-398. URL: http://www.jstor.org/stable/985644 (access date: 23.07.2023).
18. Bonnie R.J. (2002). Political Abuse of Psychiatry in the Soviet Union and in China: Complexities and Controversies // Journal of American Academy of Psychiatry and the Law. Vol. 30 Pp. 36–44.
19. Costa D.L. (2015). Health and the Economy in the United States from 1750 to the Present // Journal of Economic Literature, Vol. 53. No. 3. Pp. 503-570 DOI: 10.1257/jel.53.3.503
20. Dalal Sh., Bruera E. (2017). End-of-Life Care Matters: Palliative Cancer Care Results in Better Care and Lower costs // The Oncologist. Vol. 22 Pp. 361–368. DOI: /10.1634/theoncologist.2016-0277
21. De Soto H. (1989). The Other Path: The Invisible Revolution in the Third World. — N.Y.: Harpercollins.
22. Ehrlich I., Yin Y. (2013). Equilibrium Health Spending and Population Aging in a Model of Endogenous Growth: Will the GDP Share of Health Spending Keep Rising? // Journal of Human Capital. Vol. 7. No. 4. P. 411-447. DOI: 10.1086/675640
23. Gabrielle S., Gemma D. (2020). Defining ethical standards for the application of digital tools to population health research // Bulletin of the World Health Organization. Vol. 98. Pp. 239-244. DOI: 10.2471/BLT.19.237370
24. Gibbs J.N., Mackler B.F. (1987). Food and Drug Administration Regulation and Products Liability: Strong Sword, weak Shield // Tort & Insurance Law Journal. Vol. 22. No. 2. Pp. 194-243. http://www.jstor.org/stable/25761749
25. Gieringer, D. H. (1985). The Safety and Efficacy of New Drug Approval // Cato Journal. Vol.5. No. 1. Pp, 177–201. https://pubmed.ncbi.nlm.nih.gov/11616801/
26. Gilbert B.B (1965). The British National Insurance Act of 1911 and the Commercial Insurance Lobby. // Journal of British Studies. Vol.4. No 2. Pp. 127-148. DOI: 10.1086/385503
27. Glaeser E.L., Shleifer A. (2003). The Rise of Regulatory State // Journal of Economic Literature. Vol. 41. No 2. Pp. 401-425. DOI: 10.1257/002205103765762725.
28. Green D. (1993). Reinventing Civil Society. The Rediscovery of Welfare without Politics. — London: Civitas.
29. Gregory P. (2018). Volunteer Ambulance Services (USA) // 1914-1918-online. International Encyclopedia of the First World War / D.Ute, P. Gatrell, O. Janz, H. Jones, J. Keene, A.Kramer, B. Nasson (Eds.). Freie Universität Berlin. DOI: 10.15463/ie1418.11257.
30. Hammond-Browning N. (2017). When Doctors and Parents Don't Agree: The story of Charlie Gard. // Journal of bioethical inquiry. Vol. 14. No 4. Pp. 461–468. DOI: 10.1007/s11673-017-9814-9
31. Haun M.W., Estel S., Rücker G., Friederich H.C., Villalobos M., Thomas M., Hartmann M. (2017). Early palliative care for adults with advanced cancer // Cochrane Database of Systematic Reviews. Issue 6. Art. No.: CD011129. DOI: 10.1002/14651858.cd011129.pub2.
32. Hillman H., Nathanson V. (2001). Harvesting Organs from Recently Executed Prisoners // BMJ: British Medical Journal. Vol. 323. No. 7323. Pp:1254. DOI: 10.1136/bmj.323.7323.1254
33. Holt C., Laury S. (2002). Risk Aversion and Incentive Effects // The American Economic Review. Vol. 92. No. 5. Pp. 1644-1655. DOI: 10.1257/000282802762024700
34. Jasay A. (1985). The State. — Indianapolis: Liberty Fund.
35. Kater M. (1987). Hitler’s early doctors: Nazi physicians in pre-depression Germany // Journal of Modern History. Vol. 59. No 1. Pp. 25–52.
36. Kater M. (1983). The Nazi Party: A Social Profile of Members and Leaders, 1919–1945. — Cambridge: Harvard University Press.
37. Kulkarni P., Singh H. (2023). Artificial Intelligence in Clinical Diagnosis Opportunities, Challenges, and Hype // Journal of the American Medical Association. Published online July 6. DOI: 10.1001/jama.2023.11440.
38. Lindsey B. (1993). Cato Institute Briefing Paper. No. 19. Patient Power: The Cato Institute's Plan for HealthCare Reform October 4. https://www.cato.org/sites/cato.org/files/pubs/pdf/bp019.pdf.
39. March R. (2021). The FDA and the COVID‐19: A political economy perspective // Southern Economic Journal. Vol. 87. No 4. Pp. 1210-1228. DOI: 10.1002/soej.12494.
40. Mazurowski M. (2020). Artificial Intelligence in Radiology: Some Ethical Considerations for Radiologists and Algorithm Developers Academic // Radiology. Vol. 27. Issue 1. Pp 127-129. DOI: 10.1016/j.acra.2019.04.024.
41. Mitchell B. (2007a). International Historical Statistics: Europe 1750-2005. — London: Palgrave Macmillan.
42. Mitchell B. (2007b). International Historical Statistics: Americas 1750-2005. — London: Palgrave Macmillan,.
43. Mitchell B. (2007c). International Historical Statistics: Africa, Asia and Oceania 1750-2005. — London: Palgrave Macmillan.
44. Moore T., Zhang H., Anderson G., Alexander G. (2018). Estimated Costs of Pivotal Trials for Novel Therapeutic Agents Approved by the US Food and Drug Administration, 2015-2016 // JAMA Intern Med. Vol. 178. No. 11. Pp. 1451–1457.
45. Niskanen W. (1971). Bureaucracy and Representative Government. — Chicago: Aldine-Altherton.
46. Oster M., Shay D., Su J., Gee J., Creech C., Broder K., Edwards K., Soslow J., Dendy J., Schlaudecker E., Lang S., Barnett E., Ruberg F., Smith M., Campbell M., Lopes R., Sperling L., Baumblatt J., Thompson D., Marquez P., Strid P., Woo J., Pugsley R., Reagan-Steiner S., DeStefano F., Shimabukuro T. Myocarditis (2022). Cases Reported After mRNA-Based COVID-19 Vaccination in the US From December 2020 to August 2021 // JAMA. Vol. 327. No 4. Pp. 331-340. DOI: 10.1001/jama.2021.24110.
47. Peltzman, S. (1973). An Evaluation of Consumer Protection Legislation: The 1962 Drug Amendments // Journal of Political Economy. Vol. 81. No. 5. Pp. 1049–91. DOI: 10.1086/260107.
48. Peltzman, S. (1987). The Health Effects of Mandatory Prescriptions // The Journal of Law & Economics. Vol. 30, No. 2 (Oct.). Pp. 207-238. DOI: 10.1086/467136 .
49. Philipson T.J., Sun E. (2008). Is the Food and Drug Administration Safe and Effective? // The Journal of Economic Perspectives. Vol. 22. No. 1. Pp. 85-102. DOI: 10.1257/jep.22.1.85. (дата обращения: 23.07.2023).
50. Pritchett L., Summers L. (1996). Wealthier is Healthier // The Journal of Human Resources. Vol. 31. No. 4. Pp. 841-868.
51. Robbins S. (2019). Misdirected Principle with a Catch: Explicability for AI // Minds & Machines. Vol. 29. Pp. 495–514. DOI: 10.1007/s11023-019-09509-3.
52. Rothbard M. (2002). History of Money and Banking in the United States: The Colonial Era to World War II. — Auburn, Alabama: The Ludwig von Mises Institute.
53. Sanders E. (2004). Economic Regulation in the Progressive era in American Congress. Building of Democracy. — Boston – New York: Houghton Mifflin Company.
54. Sauer R., Sauer C. (2007). Is it Possible to Have Cheaper Drugs and Preserve the Incentive to Innovate? The Benefits of Privatizing the Drug Approval Process // Journal of Technology Transfer. Vol. 32. No. 3. Pp. 509-524. DOI: 10.1007/s10961-007-9036-0.
55. Sheingold B., Hahn J. (2014). The history of healthcare quality: The first 100 years 1860–1960. International Journal of Africa Nursing Sciences. No. 1. Pp. 18–22.
56. Singer J. (2013). Toward medical dystopia // Journal of Trauma Acute Care Surgery. Vol.75. No. 3. Pp. 517-519. DOI: 10.1097/TA.0b013e3182a040f6
57. Sullivan J. (2006). The medico-legal expertise: solid medicine, sufficient legal and a measure of common sense // Mcgill Journal of Medicine. Vol. 9 No. 2. Pp. 147-51.
58. Tullock G. (1965). The Politics of Bureaucracy. Selected works. Vol. 6 «Bureaucracy». – Indianapolis: Liberty Fund, 2005 (1st published by Public Affairs Press in 1965).
59. Wetterberg L. (2012). History of psychiatry in Sweden during a millennium // Nordic Journal of Psychiatry. Vol. 66. No. 11. Pp. 42-53. DOI: 10.3109/08039488.2011.590605.
60. Wilkinson D, Savulescu J. (2018). Ethics, conflict, and medical treatment for children: From disagreement to dissensus. – London (UK): Elsevier. PMID: 30835404. Chapter 1. The Charlie Gard case. https://www.ncbi.nlm.nih.gov/books/NBK537987/ (дата обращения: 11.07.2023).
61. Yanovskiy M., Socol Y. (2021). COVID-19 Library. Filling the Gaps. DOI: 10.2139/ssrn.3784709 .
62. Yanovskiy M., Socol Y. (2023). Looks like a conspiracy but is not a conspiracy Big Pharma or Big Government? Forthcoming in The Independent Review. A Journal of Political Economy.
63. Yanovskiy M., Zhavoronkov S. (2018). Universal Suffrage: The Century of Corrupting Incentives? // New Perspectives on Political Economy. Vol. 14. No 1-2. 2018. Pp. 63-89.